Also the elevated frequency of anti-B19 IgM class antibodies is found in ME/CFS patients in comparison with the practically healthy persons (Odds ratio 0.36, 95% CI 0.17–0.77, P = 0.009). This evidence concerns the gene CD40LG and myalgic encephalomeyelitis/chronic fatigue syndrome.